Brief: Iconovo To Evaluate ICOone Nasal For Development Of Antiviral Nasal Inhalation Product
04/04/2023 07:25
April 4 (Reuters) - Iconovo AB ICO.ST :
* ICONOVO TO EVALUATE ICOONE NASAL FOR THE DEVELOPMENT OF
ANTIVIRAL NASAL INHALATION PRODUCT
* HAS REACHED AN AGREEMENT WITH ENA RESPIRATORY PTY LTD TO
EVALUATE ICOONE® NASAL FOR DELIVERING INNA-051
* ICONOVO IS ENTITLED TO STEP-BY-STEP DEVELOPMENT SERVICE
FEES AT
A TOTAL VALUE OF UP TO SEK 0.9 MILLION OVER COMING FOUR MONTHS,
WHEREAFTER FURTHER DEVELOPMENT WORK WILL BE DISCUSSED
Source text for Eikon: ID:nMFN2MxWjt
Further company coverage: ICO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))